Sigilon Therapeutics Company
Sigilon is a biotech company which specializes in creating immune privileged products for unmet clinical needs.
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Type:
Post-IPO Equity
Investors Number:
5
Last Funding Date:
2020
Employee Number:
51-100
Total Funding:
263200000
Founded Date:
2015
Estimated Revenue:
$10M to $50M
Investor Type:
IPO
Industry:
Biotechnology